DOACs or Vitamin K Antagonists for Patients ≥ 85 With AF and Recent Stroke? DOACs or Vitamin K Antagonists for Patients ≥ 85 With AF and Recent Stroke?

Until recently, clinicians had little evidence to guide their decisions about the most effective and safe treatment for the oldest patients with atrial fibrillation and recent stroke.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Source Type: news